Skip to main content
Ipsen logo

Ipsen — Investor Relations & Filings

Ticker · IPN ISIN · FR0010259150 LEI · 549300M6SGDPB4Z94P11 PA Manufacturing
Open in API
Filings indexed 1,378 across all filing types
Latest filing 2017-03-02 Board/Management Inform…
Country FR France
Listing PA IPN

About Ipsen

https://www.ipsen.com/

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs in three key therapeutic areas: oncology, rare diseases, and neuroscience. By leveraging its specialized expertise and strategic partnerships, Ipsen aims to accelerate the development of new therapies and improve health outcomes for patients worldwide. Its strategy is centered on advancing science with purpose to bring innovative treatments from research and development to the market.

Recent filings

Filing Released Lang Actions
Communicated under the obligation to provide permanent information / Other communications
Board/Management Information Classification · 99% confidence The document is a press release dated March 2, 2017, announcing a significant change in senior management: the appointment of Benoit Hennion as Executive Vice President and President, Primary Care, and the departure of the previous incumbent. This content directly aligns with the definition of 'Board/Management Information' (MANG), which covers announcements of changes in senior management. It is not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2017-03-02 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Board/Management Information Classification · 99% confidence The document announces the appointment of Benoit Hennion as Executive Vice-President and President of General Medicine, effective March 13, 2017, and notes the departure of the previous incumbent. This content directly relates to changes in senior management personnel. This aligns perfectly with the definition for Board/Management Information (MANG). It is not an earnings release (ER), a full annual report (10-K), or a proxy statement (DEF 14A/PSI).
2017-03-02 French
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …)
M&A Activity Classification · 99% confidence The document is a press release dated February 13, 2017, announcing that Ipsen has entered into a definitive agreement to acquire a selection of consumer health products from Sanofi. This transaction involves an acquisition, which is a form of corporate activity related to M&A or financing/capital structure changes. Since the core content is the announcement of a definitive agreement for an acquisition (a takeover/merger activity), the most appropriate classification is 'M&A Activity' (TAR). It is not a full financial report (10-K or IR), an earnings release (ER), or a management discussion (MDA). It is a specific corporate transaction announcement.
2017-02-13 French
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.)
M&A Activity Classification · 99% confidence The document is a press release dated February 13, 2017, announcing that Ipsen has entered into a definitive agreement to acquire consumer healthcare products from Sanofi for €83 million cash. This announcement details a significant corporate transaction involving acquisition and financing terms. This fits the definition of M&A Activity (TAR) or potentially Capital/Financing Update (CAP). Since the core subject is the acquisition of brands (a merger/takeover proposal aspect), TAR is the most specific fit. It is not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI). Given the focus on the transaction terms and the strategic rationale, TAR is the appropriate classification.
2017-02-13 English
Information relating to the total number of voting rights and shares making up the capital
Regulatory Filings Classification · 95% confidence The document explicitly states it provides 'Monthly information regarding the total number of voting rights and total number of shares of the Company' based on Article 223-16 of the AMF General Regulations. This type of regular disclosure concerning the total share capital and voting rights structure, especially when presented in a tabular format with monthly updates, is a specific regulatory disclosure. It does not fit the definitions for Annual Report (10-K), Interim Report (IR), Earnings Release (ER), or a general Regulatory Filing (RNS). It is a specific type of regulatory disclosure related to capital structure and voting rights, which is best categorized under the general regulatory/disclosure bucket, but given the options, it most closely resembles a specific regulatory update. Since there is no specific code for 'Total Voting Rights Disclosure', I must evaluate the closest fit. It is not a Director's Dealing (DIRS), Major Shareholding (MRQ), or Dividend Notice (DIV). Given the nature of mandatory, periodic disclosure of share capital structure, and the lack of a perfect fit, I will check if any existing code covers this. 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is for results *from* a meeting. This is a running total disclosure. Since it is a mandatory regulatory disclosure that doesn't fit the other specific categories, 'RNS' (Regulatory Filings - general fallback) is the most appropriate choice, although it is a very specific type of filing.
2017-02-10 English
Information relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is titled "Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social" (Monthly information relating to the total number of voting rights and shares comprising the share capital). It explicitly references Article 223-16 of the AMF General Regulation (Autorité des Marchés Financiers, the French financial market regulator) and provides a table detailing the total number of shares and voting rights as of a specific date (January 31, 2017). This content directly relates to the structure of voting rights and share capital, which aligns best with the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA), as it reports on the total voting rights.
2017-02-10 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.